drugset / Trial / NCT02741258

Mepitel Film Treatment for the Prevention and Cutaneous Toxicity Due to Radiotherapy

NCT02741258 ↗

Phase 3 Completed 164 enrolled Dario Valcarenghi
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a randomized study, mepitel vs standard of care for the prevention and skin toxicity due to radiotherapy in patients with post-surgery breast cancer. Mepitel film will be placed on the skin of the patients just before the start of the radiotherapy and will be replaced once a week until the end of the radiotherapy. In case of skin toxicities mepitel film will be placed until resolution of toxicities.

Timeline

Start
2015-10-01
Primary completion
2021-12-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Excipial U hydrolotion Unknown — —
Comparator Flammazin Unknown — —
Comparator Ialugen Plus Unknown — —

Indications

No indication recorded.